Orbit Genomics is transforming complex disease diagnosis, treatment and prevention through early warning genomics. Our patent pending OrbiSeq™ platform analyzes novel genomic markers which uniquely reflect not only inherited predisposition to disease, but also risk acquired from lifestyle and environmental exposures. OrbiSeq can be applied to diagnose, treat and help prevent complex diseases including cancer, heart disease and neurological diseases. Our first product is an aid to diagnosis for lung cancer, the world’s deadliest cancer and the only major one without a routine screening test. Diagnosis often requires an expensive and invasive biopsy. Our simple blood test will eliminate unnecessary biopsies.
View Top Employees from Orbit GenomicsWebsite | http://www.orbitgenomics.com |
Revenue | $5 million |
Employees | 6 (5 on RocketReach) |
Address | 5331 Pinehurst Ct, Boulder, Colorado 80301, US |
Phone | (720) 515-0395 |
Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
Industry | Biotechnology Research, Software Development & Design, Software |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular Orbit Genomics employee's phone or email?
The Orbit Genomics annual revenue was $5 million in 2024.
Sarah Urfer is the Director of Laboratory Operations of Orbit Genomics.
5 people are employed at Orbit Genomics.
Orbit Genomics is based in Boulder, Colorado.
The NAICS codes for Orbit Genomics are [54, 541714, 54171, 5417, 541].
The SIC codes for Orbit Genomics are [87, 873].